Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

InnoPharmax, Inc. (4172) Income Statement

InnoPharmax, Inc. Income Statement

Last quarter (Q2 2026), InnoPharmax, Inc.'s total revenue was NT$45.12M, an increase of 94.79% from the same quarter last year. In Q2, InnoPharmax, Inc.'s net income was NT$-69.45M. See InnoPharmax, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 68.99MNT$ 32.30MNT$ 46.07MNT$ 29.13MNT$ 48.06M
NT$ 3.51MNT$ 20.76MNT$ 17.46MNT$ -377.00KNT$ 7.41M
NT$ 175.27MNT$ 110.65MNT$ 82.30MNT$ 92.95MNT$ 81.79M
Depreciation and AmortizationNT$ 6.33MNT$ 6.61MNT$ 7.25MNT$ 8.37MNT$ 9.48M
NT$ -165.44MNT$ -90.05MNT$ -53.92MNT$ -88.74MNT$ -69.77M
NT$ -171.76MNT$ -95.98MNT$ -64.84MNT$ -93.33MNT$ -74.37M
NT$ -9.13MNT$ -986.00KNT$ -5.99MNT$ -9.85MNT$ -18.59M
NT$ -180.89MNT$ -96.97MNT$ -70.83MNT$ -103.18MNT$ -92.97M
NT$ -184.40MNT$ -99.29MNT$ -70.83MNT$ -103.18MNT$ -92.97M
Per Share Metrics
Basic EPSNT$ -1.70NT$ -1.02NT$ -0.76NT$ -1.19NT$ -1.06
Diluted EPSNT$ -1.70NT$ -1.02NT$ -0.76NT$ -1.19NT$ -1.06
Weighted Average Shares Outstanding108.26M97.45M92.71M86.70M87.64M
Weighted Average Shares Outstanding (Diluted)108.26M97.45M92.71M86.70M87.64M

Currency in TWD

InnoPharmax, Inc. Earnings and Revenue History

-400M-200M0200M-450 %-300 %-150 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin